All 213 articles from FemPeptides, newest first. Search, filter by topic, or sort to find the one you need.
Why Excluding Pregnant People From Trials Creates Real Unknowns — independent evidence, practical red flags and questions to ask before considering a peptide-
Why Excluding Pregnant People From Trials Creates Real Unknowns — independent evidence, practical red flags and questions to ask before considering a peptide-
Why an Ovarian Mechanism Is Not an IVF Success Rate — independent evidence, practical red flags and questions to ask before considering a peptide-related serv
Trying to Conceive? Questions to Ask Before Continuing a Peptide Routine — independent evidence, practical red flags and questions to ask before considering a
The True Cost of a Women's Peptide Telehealth Visit — independent evidence, practical red flags and questions to ask before considering a peptide-related serv
The Menopause Testimonial Problem: Why One Story Can Feel Like a Trial — independent evidence, practical red flags and questions to ask before considering a p
The Collagen Study That Changed Its Answer When Funding Was Counted — independent evidence, practical red flags and questions to ask before considering a pept
The 40 Percent Nausea Figure: Reading Vyleesi's Real Trial Results — independent evidence, practical red flags and questions to ask before considering a pepti
Serum, Supplement, Injection, Prescription: The Women's Peptide Label Truth Table — independent evidence, practical red flags and questions to ask before cons
PT-141 Marketing vs the Vyleesi Label: Who Was Actually Studied? — independent evidence, practical red flags and questions to ask before considering a peptide
Kisspeptin and Fertility: A Fascinating Brain Signal, Not an At-Home IVF Shortcut — independent evidence, practical red flags and questions to ask before cons
'Hormone Balance' Is Not a Clinical Endpoint: How to Decode the Promise — independent evidence, practical red flags and questions to ask before considering a
GLP-1 and Oral Contraceptives: The Question a Weight-Loss Ad May Skip — independent evidence, practical red flags and questions to ask before considering a pe
Fatigue at 42: Is It Perimenopause, Iron Deficiency or Something Else? — independent evidence, practical red flags and questions to ask before considering a p
Eggs, Embryos, Pregnancies, Live Births: The IVF Endpoint Decoder — independent evidence, practical red flags and questions to ask before considering a peptid
Does a Peptide Serum Reach Its Target? The Skin-Barrier Question — independent evidence, practical red flags and questions to ask before considering a peptide
Could Female Hair Shedding Be an Iron Problem Rather Than a Peptide Problem? — independent evidence, practical red flags and questions to ask before consideri
Before-and-After Skin Photos: How Light Can Become 'Proof' — independent evidence, practical red flags and questions to ask before considering a peptide-relat
Copper Peptide Serum vs Injectable Copper Peptide: Two Products, Two Risk Profiles — independent evidence, practical red flags and questions to ask before con
Can Experimental Peptides Replace Menopause Hormone Therapy? — independent evidence, practical red flags and questions to ask before considering a peptide-rel
A Peptide Reality Check for Women: Six Questions Before Paying — independent evidence, practical red flags and questions to ask before considering a peptide-r
Do women lose more weight on tirzepatide? What the SURMOUNT trials and Lilly's sex-subgroup analyses report, which side effects women get more, and the caveats.
Thymosin alpha-1 is approved abroad for hepatitis but not in the US. What immune research and COVID studies show, the long-COVID claims, and its 2026 status.
How to store prescribed peptides and GLP-1 pens at home: reading the pharmacy label, fridge placement, light, freezing, mixed vials, discard dates and mistakes.
Wegovy pill (oral semaglutide) vs Foundayo (orforglipron): how to take each, what the trials showed, birth control and pregnancy notes, and how to choose.
Can peptides help perimenopause symptoms? Review claims involving weight, libido, sleep, energy, and recovery without falling for one-size-fits-all stacks.
Are oral peptides as effective as injections? Learn why digestion, formulation, approval status, sterility, and evidence matter more than convenience.
TB-500 (Thymosin Beta-4) promotes hair follicle migration and angiogenesis through mechanisms distinct from GHK-Cu. Here
Searching for a peptide to balance female hormones? Learn what peptides can and cannot do, which claims are unsupported, and when hormone testing makes more sense.
Which peptides are actually relevant to menopause? A careful look at weight, libido, sleep, recovery, skin, and unapproved research compounds.
NAD+ is widely marketed for perimenopause fatigue and brain fog. Here is what the biology means, what remains unproven, and what to check first.
Compare PT-141 and kisspeptin for female libido, including what is approved, what is experimental, and why low desire needs a broader evaluation.
The best peptides for women over 40 depend on the goal. Compare evidence for weight, libido, skin, recovery, and midlife energy claims.
Redness, itching, lumps or bruises after a prescribed peptide or GLP-1 injection: what's common, what the labels report, and the signs of infection or allergy.
Can semaglutide or tirzepatide help lipedema? How lipedema fat differs from obesity, what a 2025 review found (no randomized trials yet), and what to ask.
Stalled on semaglutide or tirzepatide? Why GLP-1 plateaus happen, a troubleshooting checklist for women (dose phase, protein, sleep, menopause), what to ask.
Can semaglutide or tirzepatide change your period? What the labels say about birth control and pregnancy, why weight loss shifts cycles, and the red flags.
Hair shedding on semaglutide or tirzepatide is more common in women. What the FDA labels report, why rapid weight loss triggers it, and what actually helps.
Gallstones on Wegovy or Zepbound: what the FDA labels report, why women start with higher risk, gallbladder attack symptoms, and when to get urgent care.
Can you layer copper peptides (GHK-Cu) with vitamin C, retinol, AHAs or BHAs? A practical pairing guide, a sample routine, and what's evidence vs chemistry.
AOD-9604 is sold to women as a fat-loss peptide, but its obesity program was halted after a 536-person trial showed no significant weight loss. The evidence.
CGRP is the peptide targeted by modern migraine drugs. How it links to menstrual migraine, why perimenopause can worsen attacks, and what to ask a neurologist.
Nausea and constipation are the most common GLP-1 side effects, and women report more. A week-by-week first-month plan, what the labels say, and red flags.
Creatine, collagen or peptides after 40? A goal-by-goal comparison for women (muscle, skin, bone, joints) with evidence levels and conflicts of interest.
How to fly with peptides, syringes, and cold packs. TSA rules, international customs, cold chain maintenance, and the documentation that prevents problems.
How estrogen, progesterone, and LH fluctuations across the menstrual cycle may influence peptide response. Phase-by-phase considerations for premenopausal women.
Sermorelin stimulates natural growth hormone production and may support sleep, body composition, and skin in women over 35. Evidence, limitations, and comparison to CJC/Ipa.
Research peptides for inflammatory skin conditions disproportionately affecting women. GHK-Cu, KPV, LL-37, and BPC-157 mechanisms for eczema, rosacea, and psoriasis.
Pelvic floor recovery after childbirth, surgery, or age-related weakening may involve tissue repair pathways that BPC-157 and GHK-Cu target. Here
Receptor desensitization explains why peptide effects can fade. Here
Your first peptide clinic appointment, demystified. What a good clinic does, what questions to ask, and the red flags that mean you should walk out.
Which blood tests to request before starting peptides, during a protocol, and after cycling off. IGF-1, metabolic panel, hormones, and inflammation markers explained.
MOTS-C is known for PCOS insulin resistance, but its mitochondrial mechanisms extend to bone density, exercise mimicry, and aging. Full evidence review for women.
LL-37 is a naturally occurring antimicrobial peptide relevant to chronic UTIs, biofilm infections, and autoimmune conditions — all disproportionately affecting women.
Walk into any Sephora and you'll see peptides everywhere: Matrixyl serums, Argireline eye creams, copper peptide masks. Search for peptides online and you'll find injectable protocols for…
Collagen powder from the grocery store and GHK-Cu from a peptide vendor are both called
How to organize a multi-peptide protocol: timing around meals and sleep, stacking order, menstrual cycle considerations, and when to take breaks.
The FDA PCAC met July 23-24, 2026 to review 7 peptides. Here
Orforglipron (Foundayo) is the first GLP-1 pill with no food, water, or timing restrictions. 12.4% weight loss — less than injectables, but the convenience changes the equation.
GLP-1 weight loss includes lean mass loss — and women start with less muscle to spare. The clinical data on sarcopenia risk, resistance training, protein targets, and emerging solutions.
The honest guide to peptides during perimenopause: which ones target fatigue, sleep, body composition, brain fog, and skin — and which ones are marketing noise.
PCOS has been renamed PMOS — Polyendocrine Metabolic Ovarian Syndrome. What changed, why it matters for diagnosis and treatment, and what it means for peptide therapy.
How GLP-1 receptor agonists like semaglutide and tirzepatide target PMOS at its metabolic root — reducing insulin resistance, lowering androgens, and restoring ovulation.
Anxiety disorders are twice as common in women. Selank is a Russian-developed anxiolytic peptide with a unique mechanism — here
TRIUMPH-1 showed 28.3% average weight loss — but what does retatrutide
Insulin resistance, androgen excess, LH/FSH dysregulation, chronic inflammation — the four mechanisms driving PMOS, mapped to the peptides that target each one.
Three peptides are FDA-approved for women. The rest operate in a gray area. Here
PT-141 (Vyleesi) is the only FDA-approved peptide for female desire. Everything else is hype, hope, or both. Here
Some of the claims are backed by clinical trials. Some are backed by Instagram testimonials. Here's how to tell which is which.
Why GLP-1 medications like semaglutide and tirzepatide appear to boost fertility — and why they may reduce oral contraceptive absorption. What the evidence says.
Collagen production drops roughly 30% in the first 5 years after menopause. GHK-Cu is the copper peptide with the strongest evidence for stimulating what estrogen used to maintain.
Kisspeptin can trigger egg maturation without the dangerous OHSS risk of standard IVF drugs. Here
Body size, hormonal cycles, and tolerability differ by sex — but GLP-1 dosing doesn
Women's hair loss isn't men's hair loss with a different marketing angle. The biology is distinct — and so is where peptides fit.
The best peptides for women in 2026 — ranked by goal: weight loss, skin, fertility, gut health, mood, bone, libido. Evidence-rated, honestly assessed.
KPV passed the July 2026 PCAC vote 8-6, evaluated for inflammatory conditions. Why the melanocortin pathway matters for the 2-3x female autoimmune skew.
The July 2026 PCAC meeting recommended six peptides and rejected one. A women
May 2026 renamed PCOS to PMOS. Fifteen months in, what changed for GLP-1 access, kisspeptin research, and the metabolic-first treatment picture for women.
PT-141 is FDA-approved for premenopausal HSDD - and the marketing hides the tradeoffs. Mechanism, trial data, nausea rates, hyperpigmentation risk, and who it fits.
Retatrutide hit 28.3-30.3% weight loss in TRIUMPH-1 with no clear plateau. The female-cohort read, the muscle-loss concern, and why you legally cannot get it yet.
The July 2026 PCAC vote split on sleep-relevant peptides. What each vote means for perimenopausal insomnia protocols - and what actually helps today.
The mitochondrial peptide passed the FDA panel narrowly, evaluated for osteoporosis. The honest read for postmenopausal women on the bone-density research and what changes today.
The FDA has queued GHK-Cu for compounding review by February 2027 - noninjectable routes only. What changes, what doesn
Kisspeptin sits at the top of the female reproductive hierarchy. What the trials show, why the July 2026 FDA meeting didn
Tesamorelin for women: the FDA-approved visceral fat evidence, what off-label menopause use really rests on, IGF-1 monitoring, side effects, and how it compares to GLP-1s.
Semaglutide vs metformin for PCOS insulin resistance: weight effects, evidence depth, cost, the surprise-ovulation warning, and how clinicians sequence the two.
PT-141 (Vyleesi) vs Addyi (flibanserin) head-to-head: on-demand injection vs daily pill, mechanisms, the alcohol difference, side effects, and how women actually choose.
PT-141 (bremelanotide) for women: how the desire mechanism works, what the Vyleesi trials really showed, side effects, postmenopausal questions, and 2026 access options.
The definitive guide to peptides for women: every major compound, what it's researched for, oral vs injected, life-stage recommendations, sourcing, and safety.
Which peptides have real evidence for menopause weight gain -- GLP-1s, tesamorelin for visceral fat, NAD+ and MOTS-c -- plus honest expectations and what to skip.
A complete, honest guide to peptides for menopause: what NAD+, GLP-1s, tesamorelin, GHK-Cu, DSIP, and PT-141 can support -- and what no peptide can do.
Peptides and autoimmune disease in women: KPV's inflammatory-pathway research, BPC-157's gut angle, thymosin alpha-1's double edge, and the rule that matters most.
Can peptides increase or reduce estrogen? The honest map: kisspeptin's real but limited role, why no research peptide lowers estrogen, the gyno myth, and what hormone balancing marketing…
NAD+ and perimenopause: why NAD depletion and estrogen decline hit cellular energy at the same time, what the research supports for fatigue and brain fog, and how women take it.
Does NAD+ help with menopause? A symptom-by-symptom evidence review: energy and fatigue (strongest case), hot flashes (no), metabolism, longevity, and how to try it sensibly.
Yes -- PT-141 was FDA-approved as Vyleesi in 2019 for premenopausal HSDD. What the approval covers, whether Vyleesi is still available in 2026, and the legal status of compounded and…
How to take orforglipron (Foundayo): the 0.8 mg to 17.2 mg titration schedule, timing and food rules, missed-dose guidance, the birth control 30-day rule, and interactions.
Foundayo (orforglipron) is prescription-only -- here's how legitimate access works, 2026 pricing through LillyDirect and pharmacies, generic status, and why research-only listings deserve…
Practical answers about Foundayo (orforglipron): taking it without food or water, who qualifies, birth control interactions, food noise, side effects, and missed doses.
Can women take peptides? Yes -- here's what actually determines suitability: compound status, pregnancy and hormone considerations, sourcing, and whether peptides are taken orally or…
BPC-157 through a women's health lens: the repair and gut research (and its animal-study caveat), hormone and cycle questions, pregnancy stops, oral vs injection, and sourcing.
BPC-157 for endometriosis, honestly: zero human or animal endo studies, the angiogenesis concern the hype skips, what actually has evidence, and harm-reduction rules if you still try it.
The best peptides for women over 50: muscle preservation, tesamorelin for visceral fat, NAD+ for energy, GHK-Cu for skin, bone support, PT-141, and DSIP.
The best peptides for perimenopause organized by symptom: NAD+ for fatigue, DSIP for sleep, Selank for mood, GLP-1s for weight, GHK-Cu for skin, PT-141 for libido.
A mass-market skincare ingredient is also a federal regulatory subject. Which one you're holding depends entirely on how it's delivered.
Non-injectable GHK-Cu holds Category 1 status. Injectable GHK-Cu doesn
An FDA advisory committee recommended six peptides in July 2026. Two were reviewed for conditions that fall disproportionately on women. What the vote actually changed, and what it didn
The only compound on the February docket carrying a standing warning from a major dermatology organization.
Cosmetic peptides, collagen peptides, approved peptide drugs and research peptides sit in four separate regulatory systems. How to tell which one you
Monthly cost varies enormously by peptide, dose frequency, and delivery method. Here's a realistic framework for budgeting a protocol.
Three very different pathways exist for accessing peptides. Here's how they differ in oversight, legality, and what's realistically available today.
DSIP and Semax both come up in perimenopause research conversations but target different systems entirely. Here's the head-to-head.
Glutathione's antioxidant research spans detox pathways and skin tone. Here's the mechanism, realistic expectations, and how it differs from GHK-Cu.
A plain-language reference for the terminology that comes up constantly in peptide research -- from COA to 503A to PMOS.
Now that PCOS is PMOS, here's how to think about a peptide research protocol organized around the condition's four root dysfunctions rather than symptoms alone.
Both target cellular energy, but at different points in the mitochondrial system. Here's how to think about SS-31 and NAD+ for perimenopause-related fatigue.
Some peptides carry theoretical or documented reasons for caution during preconception. Here's what to discuss with your fertility provider before continuing any protocol.
The July 23-24 FDA PCAC vote covers MOTS-c, BPC-157, DSIP, Epitalon and more. Here's what changes for women specifically under each realistic outcome.
SNAP-8 is often marketed as a needle-free alternative to injectables. Here's what the topical peptide research actually shows -- and what it doesn't.
The peptide market is largely marketed to men. Here's what to watch for when a vendor's women's-health-specific claims outrun what the underlying research supports.
PT-141 (bremelanotide) is the one FDA-approved peptide option for female low libido. Here's an honest, expectation-setting overview -- mechanism, timing, and common side effects.
BPC-157 and TB-500 both show up in post-surgical recovery research. Here's how the two mechanisms complement each other, and what to discuss with your surgeon first.
Bone loss accelerates sharply after menopause. Here's the broader peptide and collagen research landscape relevant to bone density, beyond the MOTS-c headlines.
Safety data on peptide use while breastfeeding is limited across nearly every compound. Here's an honest look at what's known, what isn't, and how to think about the decision.
A plain-language walkthrough of what a Certificate of Analysis actually tells you, and the questions to ask any vendor before you buy.
Early research is exploring high-dose collagen peptide supplementation, bone formation markers, and inflammation in endurance athletes. Here's what's emerging, with appropriate caveats.
A practical guide to evaluating Black Friday and Cyber Monday peptide promotions -- what makes a discount real, and what to watch for during the biggest sales window of the year.
Our three most-recommended vendors for women's peptide research have different strengths. Here's a straightforward comparison to help you choose.
Three research-backed peptide pairings organized by the symptom cluster they're most relevant to -- energy, skin, and sleep -- for perimenopause and menopause.
NAD+ declines faster in ovarian tissue than almost anywhere else in the body during the menopausal transition. Here
Tesamorelin is FDA-approved for visceral fat reduction — but not for the reason most searches assume. Here
Peptides and HRT are usually framed as competing choices. The research points to a different answer — and it
Kisspeptin neurons sit at the center of the hormonal changes driving perimenopause. Here
Peptide safety depends on the compound, the source, and your health status. FDA-approved peptides have established profiles. Research-grade compounds carry real uncertainty. Here is the…
GLP-1 receptor agonists like semaglutide and tirzepatide target the metabolic root of PMOS. Here is what the clinical evidence shows about insulin resistance, androgen reduction, menstrual…
PCOS has been officially renamed PMOS (Polyendocrine Metabolic Ovarian Syndrome) by global consensus in The Lancet. Here is what the name change means for your diagnosis, treatment, and why…
Retatrutide hit 30.3% weight loss in TRIUMPH-1 with no plateau. Here is what the triple-agonist data means for women specifically: visceral fat, PMOS, muscle preservation, and the reality…
IBS is 2x more common in women. BPC-157 is the most searched gut peptide and is up for FDA review July 23. Here is what the evidence actually supports for IBS, endometriosis, and gut…
Foundayo (orforglipron) is the first oral GLP-1 with no food or timing restrictions. 12.4% weight loss in a daily pill at $149/month. Here is what it means for women managing PMOS, weight…
Female hair loss is biologically distinct from male pattern baldness. GHK-Cu targets hair follicle growth through mechanisms beyond DHT suppression. Here is the evidence, the protocol, and…
Hashimoto's thyroiditis affects women 5-8x more than men. Thymosin Alpha-1 modulates the immune system, BPC-157 supports the gut-thyroid axis, and Selank addresses mood. Here is the…
PMOS is driven by four interconnected dysfunctions: insulin resistance, androgen excess, LH/FSH dysregulation, and chronic inflammation. Here is how each one works, why they feed each…
The FDA PCAC votes July 23-24 on 7 peptides including BPC-157, KPV, MOTS-C, and more. Here is what each peptide does, which ones matter most for women's health, and what outcomes to expect.
Kisspeptin is the master switch of the reproductive axis and may transform fertility treatment for women with PMOS. Here is how it triggers ovulation naturally, what the clinical trials…
80% of osteoporosis patients are women. MOTS-C, a mitochondrial peptide under FDA review July 23, promotes bone formation and inhibits resorption. Here is the science and what the vote…
Myo-inositol is the most popular supplement for PMOS. But how does it compare to GLP-1 receptor agonists and kisspeptin? A mechanism-by-mechanism comparison of the incumbent supplement vs…
BPC-157, TB-500, and GHK-Cu have wound-healing properties relevant to postpartum recovery. Here is what the evidence shows, what is safe during breastfeeding, and a realistic recovery…
PMOS is a cardiovascular risk condition, not just a reproductive one. Women with PMOS face 2-4x elevated cardiovascular risk that begins decades before events occur. Here is what the data…
An estimated 70% of women with PMOS remain undiagnosed. The old name PCOS contributed to missed diagnoses by centering ovarian cysts over the metabolic and endocrine reality. Here is why so…
How peptides like BPC-157, GHK-Cu, kisspeptin, PT-141, and NAD+ may support recovery and hormonal adaptation after hysterectomy. What every woman should know.
How anti-inflammatory peptides like BPC-157 and KPV relate to endometriosis pathology: mechanisms, limitations, and what to discuss with your doctor.
How BPC-157 and GHK-Cu may support C-section recovery: wound healing, scar remodeling, adhesion prevention, and a practical timeline for postpartum peptide use.
How the July 23-24 PCAC meeting affects women’s health: BPC-157 interstitial cystitis data, MOTS-C for PCOS, and how to submit public comment.
Complete peptide protocol for women over 50: GHK-Cu for collagen, NAD+ for energy, BPC-157 for joints, Epitalon for longevity, MOTS-C for metabolism.
How SS-31 (elamipretide) addresses cellular fatigue in women by stabilizing mitochondrial energy production. Comparison with NAD+, relevance to menopause.
How GLP-1 agonists affect oral contraceptive absorption, which peptides are safe with birth control, and why kisspeptin and hormonal contraception don’t mix.
Can you use peptides while breastfeeding? The honest answer about lactation data, molecular transfer, and the safest approach for breastfeeding mothers.
Kisspeptin in IVF trials, NAD+ for egg quality, and what to discuss with your RE. Honest assessment of the evidence for peptides in fertility treatment.
How Foundayo compares to Wegovy, Zepbound, and research GLP-1s for women: dosing convenience, weight loss data, birth control interactions, and cost.
How to use GHK-Cu for skin: topical vs injectable, DIY preparation from research-grade, commercial serums, and why it matters during perimenopause.
A symptom-by-symptom peptide guide for perimenopause: brain fog (Semax), sleep (DSIP), skin (GHK-Cu), joints (BPC-157), metabolism (MOTS-C), and anxiety (Selank).
How BPC-157 (gut healing), Thymosin Alpha-1 (immune modulation), and NAD+ (energy) relate to Hashimoto’s thyroiditis. The thyroid-gut-immune triangle explained.
How the estrobolome connects gut health to estrogen metabolism, why women get more gut disorders, and how BPC-157 and KPV support the gut-hormone axis.
New to peptides? Start here. The 5 peptides every woman should know, 3 ways to access them, a no-injection starter stack, and where to source safely.
How estrogen decline causes joint pain, which peptides (BPC-157, TB-500, GHK-Cu, KPV) address the tissue repair gap, and when to talk to your doctor.
Which peptides work orally (BPC-157, KPV) and which require injection or nasal delivery. Injection technique guide for women plus nasal peptide options.
How MOTS-C and semaglutide approach PCOS insulin resistance through different mechanisms. Comparison, fertility considerations, and what women should know.
Nobody talks about real costs. Full breakdown: consultations, labs, peptides by tier, supplies, monitoring. Comparison across protocol levels with monthly and annual estimates.
You’ve heard the word everywhere — on podcasts, in your dermatologist’s office, from that friend who swears by her “peptide protocol.” But what actually are peptides? Are they drugs…
The peptide market will nearly double to $295B by 2033. Women 50-64 are the highest GLP-1 user demographic. Yet market analysis barely acknowledges women
Collagen drops 30% in 5 years post-menopause. An evidence-based guide to skin peptides — GHK-Cu for remodeling, SNAP-8 for expression lines, Glutathione for brightening and oxidative…
Deep science on why female biology responds differently. Estrogen enhances B-cells, the X chromosome carries more immune genes, and hormonal cycles create variable peptide responses.
A 2025 report analyzed 159 women’s health organizations serving users in 180+ countries. The findings: 84% had content removed from Meta, 64% from Amazon, and 66% from Google — even when…
Women metabolize peptides differently than men. Estrogen modulates GH secretion. Body composition differs. A guide to sex-specific dosing adjustments with comparison charts.
From Phase 3 RCTs to Reddit anecdotes. Learn to evaluate peptide claims critically. Every FemPeptides-covered peptide mapped to its evidence level with a visual ladder.
On July 23-24, 2026, at FDA’s White Oak Campus in Silver Spring, Maryland, the Pharmacy Compounding Advisory Committee (PCAC) will decide the future of seven peptides that millions of…
Only 41% of clinical trial participants are women. 80% of preclinical studies use male mice. The peptide industry was built for men. Here
If you’re buying peptides from any vendor, the Certificate of Analysis (COA) is the single most important document you should review before putting anything in your body. A COA is…
1 in 10 women has PCOS. An evidence-based stacking guide covering insulin resistance (MOTS-C, semaglutide), hormonal regulation (Kisspeptin-10), and the emerging research pipeline.
You sleep eight hours and wake up exhausted. Your labs come back “normal.” Your doctor suggests exercise. You want to scream. The fatigue that plagues women — especially during…
Kisspeptin-54 achieved 23-37% pregnancy rates in IVF trials with zero cases of ovarian hyperstimulation syndrome. An evidence-based guide for women exploring peptide-assisted fertility.
IBS is 2x more common in women. An evidence-based guide to gut-healing peptides — BPC-157 for barrier repair, KPV for inflammation, and the gut-brain axis connection.
70% of drugs pulled from market had greater health risks for women. Women experience 1.5-1.7x more ADRs. The safety data gap in the peptide space — visualized.
Your peptide priorities shift with your hormones. A decade-by-decade guide with recommended stacks, hormone trajectory charts, and cost estimates for each life stage.
75% experience hot flashes. $22B annual productivity loss. 70% can
A 2024 pilot study showed BPC-157 bladder injections resolved symptoms in 10 of 12 women with severe interstitial cystitis. What this means, what the limitations are, and what
Practical guide to finding a qualified peptide therapy provider. Covers credentials, red flags, telehealth vs in-person, what to expect from your first visit, and questions to ask.
How to build a comprehensive menopause peptide protocol. Covers GH axis, metabolic support, skin/collagen, mood/sleep, and libido — with specific peptide recommendations for each axis.
Evidence-based guide to peptides for anxiety and sleep in women. Selank showed anxiolytic effects comparable to benzodiazepines. DSIP enhances delta-wave deep sleep. PubMed-cited.
ENDO-205, the first targeted peptide therapeutic for endometriosis, received FDA IND clearance in March 2026. What this means for the 190 million women affected worldwide.
Evidence-based overview of peptides relevant to postpartum recovery. Covers tissue repair (BPC-157, TB-500), collagen restoration (GHK-Cu), energy (NAD+), and safety considerations for…
TRIUMPH-1 Phase 3 data shows retatrutide achieved up to 30.3% average weight loss. Analysis of what the triple agonist means for women — menopause, HRT synergy, and the GLP-1 landscape in…
Step-by-step guide to peptide reconstitution and subcutaneous injection, written for women. Covers supplies, dosing math, injection sites, storage, and common mistakes.
Both target fat metabolism. One has FDA approval. The other avoids full GH effects. Here
Semaglutide targets GLP-1 alone. Retatrutide adds GIP and glucagon receptors for triple-agonist action. Here
Anxiety disorders are 2x more prevalent in women. Selank modulates GABA and serotonin without sedation, dependence, or cognitive impairment. Here
Selank targets anxiety through GABA/serotonin modulation. DSIP targets sleep through delta-wave promotion. Here
PT-141 (Vyleesi) is the only FDA-approved on-demand treatment for low sexual desire in women. It works on the brain, not blood flow. Phase 3 trials with 1,200+ women. Here
Women lose up to 50% of hair density by age 50. GHK-Cu reduces DHT conversion, boosts collagen in follicles, and influences 4,000+ genes. A 2026 review calls it the top peptide for women
An evidence-based review of peptides for polycystic ovary syndrome — Kisspeptin-10, MOTS-C, Semaglutide, BPC-157, and NAD+. PubMed-cited. Written for women.
Menopause affects multiple systems simultaneously — so effective peptide protocols often combine multiple compounds. Here are 5 evidence-informed stacking frameworks organized by primary…
The peptide space is full of promises — but safety starts with sourcing. Here's how to read a Certificate of Analysis, which side effects are normal, what bloodwork to monitor, and the red…
NAD+ fuels mitochondrial energy. Epitalon maintains telomere length. Both target cellular aging — through different mechanisms. Here
NAD+ decline accelerates at 45 — right when perimenopause hits. The result is a double energy crisis: estrogen drops AND cellular energy drops. Here
You didn't change your diet. You didn't stop exercising. Your body changed its fat distribution because estrogen told it to. Here are the peptides that target visceral fat at its hormonal…
A landmark study used kisspeptin-54 as an IVF trigger and produced 73 healthy babies with zero cases of ovarian hyperstimulation syndrome. Here
HRT addresses sex hormone deficiency. Peptides target the parallel axes — growth hormone, tissue repair, immune signaling — that estrogen replacement alone doesn
Glutathione depletion accelerates during menopause — driving visible aging, hyperpigmentation, and oxidative damage. Here
Women lose 30% of their collagen in the first 5 years after menopause. GHK-Cu — a naturally occurring copper peptide — stimulates collagen production, supports hair growth, and influences…
From the 2023 restrictions to the April 2026 removal — a complete timeline of what changed, what's next, and what it means for women using peptide therapy.
Epitalon reactivates telomerase, extends telomere length, and restores melatonin production from the pineal gland. It targets 5 hallmarks of aging simultaneously. Here
Perimenopause insomnia isn't just 'trouble sleeping.' It's the loss of slow-wave deep sleep — the restorative phase your brain needs to repair, consolidate memory, and regulate mood. DSIP…
The most prescribed peptide combination in functional medicine. CJC-1295/Ipamorelin restores growth hormone pulsing for sleep, body composition, skin, and the brain fog of perimenopause.
Your 40s, 50s, and 60s bring different challenges — and different peptide priorities. Here's the decade-by-decade guide to matching the right peptides to your body's changing biology.